Skip to main content
. 2022 Jun 14;11(12):1918. doi: 10.3390/cells11121918

Table 2.

Count of peripheral lymphocytes, CD3+, CD4+ and CD8+ subsets, CD40L in CD45+CD4+RO+ (expressed as percentage), and count of CD45+CD4+RO+ and CD45+CD8+RO+ expressing TNFα and IFNγ in CVID study groups. Values are reported as median (IQR).

CVID (All)
n = 47
NR
n = 17
S1 IgG R
n = 19
S1 IgG/IgA R
n = 11
HD
n = 9
Lymphocytes
(cells/mm3)
1400
(1070–1930)
1170
(525–1375)
1870
(970–2470)
1550
(1420–1770)
2530
(2438–2775)
CD3+
(cells/mm3)
1112
(758–1617)
863
(451–1198)
1280
(738–1930)
1112
(966–1314)
1960
(1767–2119)
CD3+CD4+
(cells/mm3)
641
(470–876)
490
(243–636)
641
(470–998)
876
(749–1127)
1518
(1311–1664)
CD4+ naive
(cells/mm3)
107
(33–229)
32
(14–194)
107
(53–201)
241
(87–395)
791
(600–997)
CD4+ central memory (cells/mm3) 146
(89–201)
109
(55–161)
140
(121–216)
173
(64–291)
376
(238–418)
CD4+ naïve/memory ratio 0.76
(0.41–1.05
0.56
(0.305–1.055)
0.78
(0.62–1.15)
0.83(0.55–1.05) 3.07
(2.855–5.07)
CD40L expression in CD45RO+CD4+ cells (%) 23.4
(14–36.7)
24.7
(12.8–33.95)
20.1
(9.9–26.9)
42.8
(23.4–51.8)
58.8
(50.9–62.4)
TNFα CD45RO+CD4+ (cells/mm3) 68.5
(37.2–98.4)
66.8
(30.5–98)
55.4
(31.3–77)
75.5
(66.2–117.9)
152.8
(91.7–233.5)
IFNγ CD45RO+CD4+ (cells/mm3) 27
(8.5–51.3)
29
(9.8–59.7)
10.1
(5.6–35.3)
34.3
(15.7–52.3)
48
(23–113.6)
CD3+CD8+
(cells/mm3)
542
(333–804)
482
(210.5–693.5)
736
(333–1106)
461
(382–579)
778
(730–1033)
CD8+ naive
(cells/mm3)
64
(31–117)
28
(12–56.5)
85
(34–117)
106
(68–134)
431
(313.5–496)
CD8+ central memory (cells/mm3) 19
(10–33)
17
(9.5–30.5)
24
(13–38)
19
(10–36)
19
(11.5–27)
CD8+ naïve/memory ratio 0.76
(0.41–1.05)
0.11
(0.06–0.24)
0.23
(0.11–0.3)
0.47
(0.27–0.63)
1.23
(0.71–2.61)
CD40L expression in CD45RO+CD8+ cells (%) 2.6
(0.9–6.1)
3.4
(1.35–7.5)
3.0
(1.5–12.9)
13.5
(4.1–18.3)
7.2
(4.8–10.5)
TNFα CD45RO+CD8+ (cells/mm3) 42
(24.7–79.8)
59.7
(22.75–94.25)
48.1
(34.5–82.6)
24.8
(20.7–49.8)
15.1
(11.05–26.25)
IFNγ CD45RO+CD8+ (cells/mm3) 42.7
(22.8–97)
63.4
(23.95–133.0)
42.4
(33.4–91.1)
22.8
(12.2–59.7)
24.4
(8.85–33.7)